A shortage in expertise is causing bottlenecks in the biomanufacturing space with around half of drugmakers struggling to fill processing positions, an industry report finds.

BioPharma-Reporter

Bioproduction bottlenecks increasing due to staff shortages, says report

Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has come” at the CPhI annual report press conference and recent investors in the technology echo his words.

'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI

The biopharmaceutical manufacturing sector needs better cross flow filtration technologies according to GE Healthcare, which says that advances in bioreactor systems have not been matched downstream.

Better single-use cross flow techs still needed says GE Healthcare

Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture purification services which could save clients 65% in chromatography costs in clinical manufacturing.

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

New innovations in single-use bioprocessing systems are being picked up quicker in Europe than in the US, according to ATMI.

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

Developments in single-use technology signals the end for clean-in-place biomanufacturing methods, according to ThermoFisher’s Bill Whitford.

The single-use age has dawned, says ThermoFisher

The European CMO sector is set to double in the next six years and will hit revenues of up to $20.75bn, according to Frost & Sullivan’s Aiswariya Chidambaram.

European CMO market will double in just 6 years, says Frost & Sullivan

Acuros is seeking development partnerships with Big Pharma over its recently launched water-powered drug delivery pump.

Acuros in talks with Big Pharma over water-powered delivery pump

Unilife is expanding its large dose delivery platform in a bid to meet a “growing industry need” for at-home drug administration in bigger scale.

Unilife launches Autoinfuser range publically

Detailed market knowledge and an experienced CMO are still critical to successfully developing a biopharmaceutical or biosimilar according to Cobra Biologics.

An experienced CMO is key to successful biologics development says Cobra Biologics

The biomanufacturing industry needs to adopt an integrated approach to upstream and downstream processing to boost efficiency and productivity according to EMD Millipore.

EMD Millipore talks integration: of processes; and with owner Merck KGaA

SAFC Pharma is preparing for the shift towards cell culture-based vaccines, while still supplying and growing in the traditional sector, to ensure it can grow in coming years, according to a company director.

SAFC preparing for inevitable shift to cell culture vaccines

How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event.

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

in-Pharmatechnologist&#039;s Nick Taylor looks back on BIO 2009, an event at which uncertainty about the development of the biotechnology industry’s future shape dominated proceedings.

BIO 2009: snapshot of an evolving biotech industry

Breaking News on Biopharmaceutical Development and Manufacturing

hubhopper

BioPharma-Reporter

hubhopper